Kamada (KMDA) Times Interest Earned (2012 - 2026)
Kamada (KMDA) posted quarterly Times Interest Earned of -$36.98 for Q1 2026, down 191.1% year-on-year from $40.6 in Q1 2025, and down 13.59% on a QoQ basis from -$32.56 in Q4 2025.
Kamada (KMDA) Times Interest Earned (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Times Interest Earned for 15 consecutive years, with -$36.98 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned fell 191.1% year-over-year to -$36.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43679.0 (down 2424.49% YoY) and the FY2025 annual result came in at $30.36, changed 0.06% from the prior year.
- Times Interest Earned fell to -$36.98 in Q1 2026 per KMDA's latest filing, from -$32.56 in the prior quarter.
- Over the last five years, Times Interest Earned for KMDA reached as high as $12142.2 in Q3 2022 and fell as low as -$91004.8 in Q2 2025.
- A 5-year average of -$4849.5 and a median of -$12.14 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned jumped 92023.51% — and 2025, when it sank 234066.17%.
- Year by year, Times Interest Earned stood at -$12.14 in 2022, then plunged by 189.47% to -$35.14 in 2023, then sank by 45.21% to -$51.03 in 2024, then soared by 36.19% to -$32.56 in 2025, then declined by 13.59% to -$36.98 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$36.98, -$32.56, and $55.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -36.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.98 |
| Dec 31, 2025 | -32.56 |
| Sep 30, 2025 | 55.75 |
| Jun 30, 2025 | -91,004.77 |
| Mar 31, 2025 | 40.60 |
| Dec 31, 2024 | -51.03 |
| Sep 30, 2024 | -58.65 |
| Jun 30, 2024 | 38.90 |
| Mar 31, 2024 | 25.40 |
| Dec 31, 2023 | -35.14 |
| Sep 30, 2023 | -4,074.63 |
| Jun 30, 2023 | -3.62 |
| Mar 31, 2023 | 578.00 |
| Dec 31, 2022 | -12.14 |
| Sep 30, 2022 | 12,142.18 |
| Jun 30, 2022 | -12.33 |
| Mar 31, 2022 | -1.27 |
| Dec 31, 2021 | 3.00 |
| Sep 30, 2021 | 13.18 |
| Jun 30, 2021 | 16.60 |